Sponsors
Aidan Gannon and Jessica Perry Examine the Patient-centric Revolution
In this episode, Aidan Gannon of Advarra and Jessica Perry of Moderna discuss patient centricity in clinical research.
Beginner’s Guide to IND Safety Reporting Under 21 CFR 312(c)
Learn how to ensure compliance with FDA 21 CFR 312.32, and explore Advarra solutions that support efficient and compliant safety reporting.
Study Activation: Top Four Takeaways from Research Sites
How can sponsors leverage their relationship with their sites to ensure more efficient research?
Understanding the Current and Future States of Cell and Gene Therapy Research
This white paper focuses on gene therapy uses in oncology and looks at a successful program at an NCI-designated comprehensive cancer center.
How to Successfully Conduct Virtual Investigator Meetings
Explore best practices to conduct virtual investigator meetings to increase comprehension and expedite site activation.
Advarra Announces Key Growth Milestone for The Gene Therapy Ready Network, Becoming Largest IBC Service
Advarra's network has grown to over 500 registered research sites, becomes the largest administrator of institutional biosafety committees
Cell & Gene Therapy vs Drug Research: What’s the Difference?
In the past year, cell and gene therapy research has exploded. Understand how this field differs from traditional drug development.
Addressing Barriers to DEI in Clinical Research
A diverse, equitable, & inclusive research environment benefits everyone: trials & the communities alike. How can sites incorporate more DEI?
Making the Most of Site Training: Lessons from the Pandemic
Ensure that your next remote site initiation visit is both productive and useful despite the virtual setting with these tips
The Power Of Patient Advocacy In Drug Development
This blog outlines the origins and rise of patient advocacy groups, discussing the milestones in the FDA's acceptance of these groups.
Q&A from Remote Monitoring: Study Compliance In A Changing World
In a recent webinar, Advarra experts provided insights and information in Remote Monitoring: Study Compliance in a Changing World
Pitfalls of Chemistry, Manufacturing, and Controls in Investigational New Drug Preparation
Submitting an Investigational New Drug (IND) application for the first time? Consider three common CMC pitfalls that may impact submission.
Subscribe to our monthly email
Receive updates monthly about webinars for CEUs, white papers, podcasts, and more.
Advancing Clinical Research: Safer, Smarter, Faster™
Copyright © 2025 Advarra. All Rights Reserved.